Results 171 to 180 of about 19,263 (243)

Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial. [PDF]

Nat Commun
Ostendorf L, Zernicke J, Klotsche J, Kempkens R, Beenken AE, Biesen R, Cheng Q, Khodadadi L, Guerra GM, Heinrich F, Durek P, Burmester GR, Krönke G, Hiepe F, Mashreghi MF, Alexander T.   +15 more
europepmc   +1 more source

Treatment with Daratumumab in Combination with Glucocorticosteroids as First-Line Treatment Achieves a Complete Remission for a Patient with Multiple Myeloma and Resolves Neutropenia: A Case Report. [PDF]

Case Rep Oncol
Mettias S, Cheung J, Moore J, Berenson JR.   +3 more
europepmc   +1 more source

Available IPD datapackage for study 'A Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy'

Johnson & Johnson
openalex   +1 more source

EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma [PDF]

, 2018
Kyriaki Tzogani, Elisabeth I Penninga, Marie Louise Schougaard Christiansen, Doris Hovgaard, Sinan B. Sarac, Jorge Camarero Jiménez, Isabel García, Marta Lafuente, Arantxa Sancho-López, Tomas Salmonson, Christian Gisselbrecht, Francesco Pignatti   +11 more
openalex   +1 more source

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]

J Immunol Res
Gnann DC, Steinke S, Garritsen HSP, Hust M.   +3 more
europepmc   +1 more source

Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review [PDF]

Xiaoyu Jing, Dongjun Li, Shao Bo Su, Qingkai Dai, Shuwen Sun, Liang Huang, Yuan Ai, Ju Gao, Yi-Ping Zhu, Jiaqi Ni, Xiaoxi Lu   +10 more
openalex   +1 more source

Case report: anti-GAD65 antibody-associated epilepsy as the primary manifestation of chronic graft-versus-host disease. [PDF]

Ann Hematol
Yang S, Gu P, Tian J, Tang X, Xue Q.
europepmc   +1 more source

Safety and efficacy of daratumumab in immune thrombocytopenia. [PDF]

Blood Adv
Tsykunova G, Holme PA, Tran HTT, Frederiksen H, Tjønnfjord E, Munthe LA, Drivet E, Kared H, Sørvoll IH, Ahlen MT, Mahévas M, Michel M, Bussel J, Kuter DJ, Anderson Tvedt TH, Ghanima W.   +15 more
europepmc   +1 more source

Inconsistency between serum IgG κ and glomerular IgA λ chain types in proliferative glomerulonephritis with monoclonal deposits successfully treated with daratumumab-based therapy. [PDF]

Medicine (Baltimore)
Chen H, Chen D, Zhang G, Cheng M, Jin J, Niu Z, Zhu R, Guo L, Wang J, Bai Y, Xu J, Cheng Z.   +11 more
europepmc   +1 more source

Supplementary Figure 2 from <i>Ex Vivo</i> Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies

Alana L. Keller, Lauren T. Reiman, Olivia Perez de, Sarah E. Parzych, Peter A. Forsberg, Peter Kim, Kamlesh Bisht, Hongfang Wang, Helgi van de Velde, Daniel W. Sherbenou   +9 more
openalex   +1 more source